Financhill
Back

Regenxbio Quote, Financials, Valuation and Earnings

Regenxbio Price Quote

$7.65
+0.02 (+3.24%)
(Updated: December 21, 2024 at 5:44 AM ET)

Regenxbio Key Stats

Sell
9
Regenxbio (RGNX) is a Sell

Day range:
$7.21 - $7.75
52-week range:
$7.21 - $28.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.32
P/B ratio:
1.25%

Volume:
10.5M
Avg. volume:
1.5M
1-year change:
-58.31%
Market cap:
$378M
Revenue:
$90.2M
EPS:
$-5.02

How Much Does Regenxbio Make?

Data Unavailable

Is Regenxbio Growing As A Company?

Data Unavailable

Regenxbio Stock Price Performance

  • Did Regenxbio Stock Go Up Last Month?
    Regenxbio share price went down by -20.77% last month
  • Did RGNX's Share Price Rise Over The Last Year?
    RGNX share price fell by -58.31% over the past 1 year

What Is Regenxbio 52-Week High & Low?

  • What Is Regenxbio’s 52-Week High Share Price?
    Regenxbio has traded as high as $28.80 over the past 52 weeks
  • What Is Regenxbio’s 52-Week Low Share Price?
    Regenxbio has traded as low as $7.21 over the past 52 weeks

Regenxbio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Regenxbio?

Data Unavailable

Is Regenxbio Cash Flow Positive?

Data Unavailable

Regenxbio Return On Invested Capital

Data Unavailable

Regenxbio Earnings Date & Stock Price

  • What Is Regenxbio's Stock Price Today?
    A single share of RGNX can be purchased today for 7.63
  • What Is Regenxbio’s Stock Symbol?
    Regenxbio trades on the nasdaq under the ticker symbol: RGNX
  • When Is Regenxbio’s Next Earnings Date?
    The next quarterly earnings date for Regenxbio is scheduled on February 27, 2025
  • When Is RGNX's next ex-dividend date?
    Regenxbio's next ex-dividend date is December 22, 2024
  • How To Buy Regenxbio Stock?
    You can buy Regenxbio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Regenxbio Competitors

  • Who Are Regenxbio's Competitors?
    Below is a list of companies who compete with Regenxbio or are related in some way:
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Edgewise Therapeutics Inc (EWTX)
    • Sarepta Therapeutics Inc (SRPT)
    • Entrada Therapeutics Inc (TRDA)
    • Vertex Pharmaceuticals Inc (VRTX)

Regenxbio Dividend Yield

Data Unavailable

Regenxbio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -6.58%
Revenue: -16.31% -0.82%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 37.64
Upside from Last Price: 393.27%

Major Shareholders

Data Unavailable